MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31.

Income Overview

Net Income
-$74,111K
EPS
-$1.06
Unit: Thousand (K) dollars

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Research and development
60,819 49,889* 54,178 55,703
General and administrative
21,953 19,040* 17,100 17,462
Total operating expenses
82,772 68,929 71,278 73,165
Loss from operations
-82,772 -68,929* -71,278 -73,165
Interest income, net
8,740 9,842 6,318 7,141
Total other income, net
8,740 9,842* 6,318 7,141
Net loss before taxes
-74,032 -59,088* -64,960 -66,024
Provision for income taxes
79 79* 61 72
Net loss after taxes
-74,111 -59,167 -65,021 -66,096
Basic EPS
-1.06 -0.912 -1.11 -1.13
Diluted EPS
-1.06 -0.912 -1.11 -1.13
Basic Average Shares
69,668,439 64,870,385 58,773,731 58,428,344
Diluted Average Shares
69,668,439 64,870,385 58,773,731 58,428,344
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net loss after taxes-$74,111K Interest income, net$8,740K Net loss beforetaxes-$74,032K Provision for income taxes$79K Total other income,net$8,740K Loss from operations-$82,772K Total operatingexpenses$82,772K Research and development$60,819K General andadministrative$21,953K

Apogee Therapeutics, Inc. (APGE)

Apogee Therapeutics, Inc. (APGE)